Marc‐André Laplante

657 total citations
14 papers, 507 citations indexed

About

Marc‐André Laplante is a scholar working on Physiology, Biochemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Marc‐André Laplante has authored 14 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 6 papers in Biochemistry and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Marc‐André Laplante's work include Eicosanoids and Hypertension Pharmacology (6 papers), Nitric Oxide and Endothelin Effects (4 papers) and Renin-Angiotensin System Studies (3 papers). Marc‐André Laplante is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (6 papers), Nitric Oxide and Endothelin Effects (4 papers) and Renin-Angiotensin System Studies (3 papers). Marc‐André Laplante collaborates with scholars based in Canada, France and Finland. Marc‐André Laplante's co-authors include Jacques de Champlain, Rong Wu, Adil El Midaoui, Hélène Girouard, Lingyun Wu, Maria Karas, Laurent Monassier, Pascal Bousquet, Pierre Moreau and Fabrice Jaffré and has published in prestigious journals such as Free Radical Biology and Medicine, Endocrinology and Hypertension.

In The Last Decade

Marc‐André Laplante

14 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc‐André Laplante Canada 10 189 177 137 105 89 14 507
Paul Modlinger United States 8 211 1.1× 251 1.4× 135 1.0× 129 1.2× 86 1.0× 9 653
Glenn Solis United States 12 145 0.8× 153 0.9× 125 0.9× 76 0.7× 71 0.8× 14 437
Montserrat Cruzado Argentina 14 150 0.8× 202 1.1× 158 1.2× 51 0.5× 160 1.8× 20 563
Shinji Matsuba Japan 9 254 1.3× 131 0.7× 145 1.1× 53 0.5× 136 1.5× 13 555
Toshihiro Matsuzaki Japan 14 147 0.8× 233 1.3× 125 0.9× 62 0.6× 51 0.6× 38 576
Malarvannan Pannirselvam Canada 11 190 1.0× 402 2.3× 152 1.1× 169 1.6× 85 1.0× 13 614
Wolfgang Siebeneich United States 10 173 0.9× 347 2.0× 80 0.6× 84 0.8× 80 0.9× 12 581
Kazutoshi Nakazono Japan 2 208 1.1× 335 1.9× 147 1.1× 149 1.4× 92 1.0× 7 635
Subbarao Vemulapalli United States 17 283 1.5× 211 1.2× 219 1.6× 48 0.5× 114 1.3× 37 725
J. Skopec United States 6 224 1.2× 339 1.9× 65 0.5× 122 1.2× 76 0.9× 6 540

Countries citing papers authored by Marc‐André Laplante

Since Specialization
Citations

This map shows the geographic impact of Marc‐André Laplante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc‐André Laplante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc‐André Laplante more than expected).

Fields of papers citing papers by Marc‐André Laplante

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc‐André Laplante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc‐André Laplante. The network helps show where Marc‐André Laplante may publish in the future.

Co-authorship network of co-authors of Marc‐André Laplante

This figure shows the co-authorship network connecting the top 25 collaborators of Marc‐André Laplante. A scholar is included among the top collaborators of Marc‐André Laplante based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc‐André Laplante. Marc‐André Laplante is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Avramoglu, Rita Kohen, Marc‐André Laplante, Khaï Le Quang, et al.. (2013). The Genetic and Metabolic Determinants of Cardiovascular Complications in Type 2 Diabetes: Recent Insights from Animal Models and Clinical Investigations. Canadian Journal of Diabetes. 37(5). 351–358. 4 indexed citations
2.
Laplante, Marc‐André, Alexandre Charbonneau, Rita Kohen Avramoglu, et al.. (2013). Distinct metabolic and vascular effects of dietary triglycerides and cholesterol in atherosclerotic and diabetic mouse models. American Journal of Physiology-Endocrinology and Metabolism. 305(5). E573–E584. 7 indexed citations
3.
Wu, Rongqian, et al.. (2011). Cyclo-Oxygenase-2 Knockout Genotype in Mice Is Associated With Blunted Angiotensin II-Induced Oxidative Stress and Hypertension. American Journal of Hypertension. 24(11). 1239–1244. 11 indexed citations
4.
Laplante, Marc‐André, Laurent Monassier, Monique Freund, Pascal Bousquet, & Christian Gachet. (2010). The Purinergic P2Y1 Receptor Supports Leptin Secretion in Adipose Tissue. Endocrinology. 151(5). 2060–2070. 33 indexed citations
5.
Monassier, Laurent, Marc‐André Laplante, Fabrice Jaffré, et al.. (2008). Serotonin 5-HT 2B Receptor Blockade Prevents Reactive Oxygen Species–Induced Cardiac Hypertrophy in Mice. Hypertension. 52(2). 301–307. 42 indexed citations
6.
Laplante, Marc‐André & Jacques de Champlain. (2006). The interrelation of the angiotensin and endothelin systems on the modulation of NAD(P)H oxidaseThis paper is one of a selection of papers published in this Special issue, entitled Young Investigator's Forum.. Canadian Journal of Physiology and Pharmacology. 84(1). 21–28. 14 indexed citations
7.
Wu, Rong, Marc‐André Laplante, & Jacques de Champlain. (2005). Cyclooxygenase-2 Inhibitors Attenuate Angiotensin II–Induced Oxidative Stress, Hypertension, and Cardiac Hypertrophy in Rats. Hypertension. 45(6). 1139–1144. 56 indexed citations
8.
Champlain, Jacques de, Rong Wu, Hélène Girouard, et al.. (2004). Oxidative Stress in Hypertension. Clinical and Experimental Hypertension. 26(7-8). 593–601. 168 indexed citations
9.
Laplante, Marc‐André, Rong Wu, Pierre Moreau, & Jacques de Champlain. (2004). Endothelin mediates superoxide production in angiotensin II-induced hypertension in rats. Free Radical Biology and Medicine. 38(5). 589–596. 48 indexed citations
10.
Wu, Rong, Marc‐André Laplante, & Jacques de Champlain. (2004). Prevention of angiotensin II-induced hypertension, cardiovascular hypertrophy and oxidative stress by acetylsalicylic acid in rats. Journal of Hypertension. 22(4). 793–801. 52 indexed citations
11.
Millette, Esther, Rong Wu, Marc‐André Laplante, et al.. (2003). Comparison of the cardiovascular protection by omapatrilat and lisinopril treatments in DOCA-salt hypertension. Journal of Hypertension. 21(1). 125–135. 14 indexed citations
12.
Laplante, Marc‐André, Rong Wu, Adil El Midaoui, & Jacques de Champlain. (2003). NAD(P)H oxidase activation by angiotensin II is dependent on p42/44 ERK-MAPK pathway activation in rat's vascular smooth muscle cells. Journal of Hypertension. 21(5). 927–936. 55 indexed citations
13.
Laplante, Marc‐André. (2001). Hypotensive effect of genistein in angiotensin-treated hypertensive rats; implication of the ERK-MAPK pathway and the superoxyde anion radical. American Journal of Hypertension. 14(11). A25–A25. 1 indexed citations
14.
Laplante, Marc‐André, et al.. (1973). [Etiology and pathogenesis of idiopathic Parkinsonism: a model].. PubMed. 14(5). 287–307. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026